<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="to active transport of the danger associated molecular pattern (DAMP)" exact="adenosine" post="triphosphate (ATP) out of the cell, resulting in immunogenic"/>
 <result pre="of immunotherapy drugsNat. Rev. Drug Discov.20151464266226323545 15.HodiFSet al.Improved survival with" exact="ipilimumab" post="in patients with metastatic melanomaN. Engl. J. Med201036371172320525992 16.CarboneDPet"/>
 <result pre="in patients with metastatic melanomaN. Engl. J. Med201036371172320525992 16.CarboneDPet al.First-line" exact="nivolumab" post="in stage IV or recurrent non-small-cell lung cancerN. Engl."/>
 <result pre="lung cancerN. Engl. J. Med.20173762415242628636851 17.WolchokJDet al.Overall survival with combined" exact="nivolumab" post="and ipilimumab in advanced melanomaN. Engl. J. Med.20173771345135628889792 18.BarlesiFet"/>
 <result pre="Engl. J. Med.20173762415242628636851 17.WolchokJDet al.Overall survival with combined nivolumab and" exact="ipilimumab" post="in advanced melanomaN. Engl. J. Med.20173771345135628889792 18.BarlesiFet al.Avelumab versus"/>
 <result pre="ipilimumab in advanced melanomaN. Engl. J. Med.20173771345135628889792 18.BarlesiFet al.Avelumab versus" exact="docetaxel" post="in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN"/>
 <result pre="future opportunities and challenges. Curr. Oncol.10.3747/co.25.3840 (2018). 22.RittmeyerAet al.Atezolizumab versus" exact="docetaxel" post="in patients with previously treated non-small-cell lung cancer (OAK):"/>
 <result pre="measles virus therapyMol. Ther.2014221949195925156126 26.PuzanovIet al.Talimogene laherparepvec in combination with" exact="ipilimumab" post="in previously untreated, unresectable stage IIIB-IV melanomaJ. Clin. Oncol.2016342619262627298410"/>
 <result pre="virotherapy for cancer therapyOncolytic Viroth20154183191 117.HamanoSet al.Oncolytic reovirus combined with" exact="trastuzumab" post="enhances antitumor efficacy through TRAIL signaling in human HER2-positive"/>
 <result pre="human HER2-positive gastric cancer cellsCancer Lett.201535684685425444894 118.LaengleJet al.Histone deacetylase inhibitors" exact="valproic acid" post="and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosisJ. Immunother. Cancer20208e00019531940587"/>
 <result pre="cancer cellsCancer Lett.201535684685425444894 118.LaengleJet al.Histone deacetylase inhibitors valproic acid and" exact="vorinostat" post="enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosisJ. Immunother. Cancer20208e00019531940587 119.PetricevicBet al.Trastuzumab"/>
</results>
